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Abstract 24 
Free living amoebae of the genus Acanthamoeba are the causal agents of a sight 25 
threatening ulceration of the cornea called Acanthamoeba keratitis, and the rare but 26 
usually fatal granulomatous amoebic encephalitis. Although there are many therapeutic 27 
options for the treatment of Acanthamoeba infections, they are generally lengthy and/or 28 
have limited efficacy. For the best clinical outcome, the treatments should target both the 29 
trophozoite and the cyst stages as the later are known to confer resistance to treatment.  30 
In this study we document the activity of caffeine and maslinic acid against both the 31 
trophozoite and the cyst stages of three clinical strains of Acanthamoeba. These drugs 32 
were chosen because they are reported to inhibit glycogen phosphorylase which is 33 
required for encystation. Maslinic acid is also reported to be an inhibitor of extracellular 34 
proteases which may be relevant since the protease activity of Acanthamoeba is correlated 35 
with their pathogenicity.  We also provide evidence or the first time that both drugs exert 36 
their anti-amoebal effects through programmed cell death. 37 
 38 
Keywords: Acanthamoeba, caffeine, maslinic acid, Programmed Cell Death. 39 
  40 
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 41 
INTRODUCTION 42 
The genus Acanthamoeba are ubiquitous protists which are the causative agents of several 43 
opportunistic infections in humans such as a sight-threating ulceration of the cornea 44 
known as Acanthamoeba Keratitis (AK), the usually fatal Granulomatous Amoebic 45 
Encephalitis (GAE) and also a range of disseminated infections, usually, but not 46 
exclusively, limited to the skin (1-4). 47 
The life cycle of Acanthamoeba alternates between two stages: the trophozoite, which is 48 
the active growing stage, and the cyst which is a dormant stage resorted to when 49 
conditions become incompatible with growth.  The cyst has a highly resistant double wall.  50 
The outer wall is fibrous and composed mainly of protein while the inner wall is of a 51 
granular nature and contains more than 30% cellulose (2, 5, 6, 7). In AK, the cyst is 52 
responsible for recurrent amoebic infections, as it is able to survive many of the current 53 
treatments (8, 9) and differentiate back to amoebae on the cessation of treatment. 54 
Diamidines (proamidine and hexamidine) and biguanides (chlorhexidine and 55 
polyhexamethylene biguanide (PHMB)), have been found to be effective against 56 
Acanthamoeba trophozoites and cysts in vitro (2, 3, 4, 10). However, it has been reported 57 
that about 5% of patients with AK are troubled with inflammation due to the presence of 58 
Acanthamoeba cyst surviving in the cornea, even after prolonged treatment with these 59 
agents (11). There is an urgent need for more effective treatments and so there is also a 60 
need to identify and validate new therapeutic targets against Acanthamoeba mostly 61 
focusing on key proteins related to cellular viability and the pathogenic mechanisms.  In 62 
this report we explore two such targets, the secreted proteases and glycogen 63 
phosphorylase. 64 
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Acanthamoeba secretes three types of proteolytic enzymes: serine, cysteine and metalo-65 
proteases and these are at least part of the organism’s pathogenicity (12). RNAi silencing 66 
experiments confirm this (13, 14), and it has been demonstrated that serine proteases play 67 
a role in the important processes of encystment and excystation (13, 15, 16). 68 
Glycogen phosphorylase is active during encystation in breaking down glycogen to 69 
release glucose-1-phosphate, a precursor of the cellulose required to construct the inner 70 
cyst wall. We have shown that the inhibition of this enzyme by RNAi blocks the 71 
formation of cysts (14).  However, a drug which performed the same function is 72 
preferable in the treatment of AK since RNAi is not yet widely approved. 73 
 Caffeine and maslinic acid are reported to be glycogen phosphorylase inhibitors (17, 18). 74 
Maslinic acid is a natural triterpene isolated from olive tree (Olea europea) with multiple 75 
biological properties, such as antimicrobial and antiparasitic activity (19, 20, 21, 22). 76 
Maslinic acid has been reported to be a potent inhibitor of glycogen phosphorylase and 77 
extracellular proteases of parasites such as Toxoplasma gondii and serine-proteases from 78 
Cryptosporidium (19, 23, 24, 25, 26). 79 
 80 
RESULTS 81 
Caffeine and maslinic acid were both amoebicidal and cysticidal. Caffeine and 82 
maslinic acid were both active against the trophozoite stage of different strains of 83 
Acanthamoeba. Caffeine has higher activity than maslinic acid (except for strain CLC-84 
16) (Table 1). Although both products seem to have a lower activity than chlorhexidine, 85 
their activity is still higher that the other reference drug, amphotericin B (Table 1).  86 
When cells were grown in encystation medium and stained with Congo Red in order to 87 
analyse by flow cytometry, control cells were clearly divided in 3 main populations: P3 88 
trophozoites; P4 cysts stained with Congo Red; P5 pre-cysts stained with Congo Red 89 
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(Figure 1A). However, after the treatments using caffeine and maslinic acid, trophozoites 90 
were unable to neither encyst nor form mature cysts (Figure 1B, 1C). 91 
The effect of caffeine and maslinic acid on cell proliferation from 24 to 72 h was checked. 92 
It was noted that both active principles decreased the cell proliferation in a dose-93 
dependent manner (Figure 2). Furthermore, significant differences between the control 94 
and the IC50 and IC90 were observed (except at 24h when maslinic acid was used (Figure 95 
2B)) and no significant differences between both concentrations were observed, which 96 
may serve to establish the IC50 as the concentration sufficient to eliminate the cell 97 
population. 98 
Caffeine and maslinic acid showed low cytotoxicity to vertebrate cells. The results 99 
showed that caffeine (both IC50 and IC90, C50 and C90 respectively for Acanthamoeba) 100 
and maslinic acid IC50 (M50) were not cytotoxic toward HeLa or J774.A1 vertebrate cells. 101 
Caffeine and maslinic acid showed significantly low cytotoxicity compared to the 102 
reference drugs chlorhexidine and amphotericin B (Figure 3). 103 
Caffeine and maslinic acid induce larger amount of DNA in the cell lysate than in 104 
the supernatant. When Acanthamoeba Neff was treated with the IC50 and IC90 of 105 
caffeine and maslinic acid, a larger amount of DNA was observed in the cell lysate 106 
compared to the detected levels in the supernatant (Fig. 4). Therefore, a higher amount of 107 
intracellular DNA was detected in all cases with significant differences between the 108 
detected DNA in the lysate and the supernatant. Just in the case of caffeine (Fig. 4A), 109 
significant differences between the used concentrations were also observed at 48h after 110 
the treatment.  111 
Caffeine and maslinic acid induce PCD which can be observed with double stain 112 
assay. When double staining was performed, caffeine and maslinic acid caused nuclei 113 
staining with Hoechst demonstrating the presence of condensed chromatin (Fig. 5). 114 
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Moreover, the differences between the three cells population were clear and thus live cells 115 
were detected under fluorescence microscopy as they showed faint blue nuclei against a 116 
high cytoplasmic background stain (Fig. 5D) whereas cells displaying PCD presented 117 
bright blue nuclei due to karyopyknosis and chromatin condensation (Fig 5E-F).  Dead 118 
cells were not able to exclude propidium iodide, a DNA binding dye, and so the remnant 119 
of the nuclei in these dead cells stained red (Fig 5G-I). These images show that both 120 
caffeine and maslinic acid caused PCD after 24 hours 121 
Caffeine and maslinic acid cause plasma membrane permeability. Treated amoebae 122 
with caffeine and maslinic acid induced cellular membrane damage after 1 h of treatment. 123 
None of the tested products induced the same level of fluorescence observed in the 124 
positive control (Fig. 6D). Nevertheless, cellular membrane disruption was checked and 125 
confirmed using fluorescence microscopy in treated cells (Fig. 6A-C).  126 
Amoebae treated with caffeine and maslinic acid showed signs of early PCD. 127 
Acanthamoeba Neff treated with the assayed active principles showed externalization of 128 
PS. Number of cells suffering PCD or death were counted and show a clearly different 129 
between the control and the treated cells (Fig. 7). Moreover, the statistical analyses 130 
showed significant differences in the percentage of detected PCD cells after treatment 131 
with all the assayed drugs respect to the control. Therefore, early stages of apoptosis in 132 
the treated Acanthamoeba cells were demonstrated. 133 
Acanthamoeba caspase-3-like activity was detected after treatment with caffeine and 134 
maslinic acid. A significant caspase-3-like activity was detected in amoebae treated with 135 
caffeine or maslinic acid using a chromogenic probe attached to a substrate peptide. 136 
Caspase-3 like activity developed in the presence of both drugs especially after 24 hrs.   137 
 138 
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DISCUSSION 139 
Caffeine and maslinic acid are glycogen phosphorylase inhibitors (17, 18) and maslinic 140 
acid inhibits the extracellular protease in a number of different parasites (19, 23, 24, 25, 141 
26). Their activity had been successfully tested against different protozoa (19, 20, 23, 24, 142 
25, 26), and maslinic acid has been found to be active against Acanthamoeba (22). In the 143 
present study, anti-Acanthamoeba activity of these drugs has been described using a range 144 
of Acanthamoeba strains. The fact that both drugs have an anti-cyst activity had been 145 
established by viability and proliferative assay and analyzed by flow cytometry in this 146 
study.  The finding that both drugs blocked the development of cysts is compatible with 147 
their inhibitory effects both on proteases and on the glycogen phosphorylase activity that 148 
is required for glucose release from glycogen to form the cellulose wall (6), but this does 149 
not explain caffeine’s toxic effect on trophozoites. However, it is known that caffeine and 150 
maslinic acid induces apoptosis in various vertebrate cell types, for example caffeine 151 
induce PCD in neuroblastoma cells, pancreatic and lung adenocarcinoma (27, 28, 29, 30) 152 
and maslinic acid induces apoptosis in metastatic cell lines and in colon cancer cells (31, 153 
32). We could find no study in which either drug was reported to induce PCD in any 154 
protist.  155 
PCD and PCD-like processes have been reported in a wide variety of protists (33), 156 
including Acanthamoeba (33, 34, 35, 36, 37).  The present study has shown that caffeine 157 
and maslinic acid activate PCD and markers such as externalization of 158 
phosphatidylserine, chromatin condensation and DNA fragmentation.  We also found 159 
evidence for the involvement of a caspase-3-like enzyme since the well-known DEVD-160 
pnitroalanine caspase-3 substrate was cleaved in Acanthamoeba.  Caspase-3 is an effector 161 
caspase, leading to DNA fragmentation, chromatin condensation and membrane 162 
disruption. Other members of the family of caspases are the metacaspases and 163 
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paracaspases, the latter have been found in plants, fungi and protozoa and their function 164 
is not limited to cell death, but have roles in sporulation, embryogenesis (38, 39, 40). In 165 
Acanthamoeba, a type-1 metacaspase has been identified. Its function is related to 166 
encystment (41), and activity relating to the osmoregulation processes has also been 167 
inferred (42). Our group has previously found caspase-3-like activity stimulated by statin 168 
drugs in Acanthamoeba by the same method (34), and others have reported that violacein 169 
induces caspase-3 activity in Acanthamoeba (43) but we can find no obvious caspase-3 170 
homologs in the various Acanthamoeba genome databases. It is possible that the 171 
Acanthamoeba enzyme that recognises and cleaves this motif belongs to a different 172 
protease family. 173 
Treatment that induces necrosis in parasites produce an inflammatory response in the host 174 
(44), so it is important to avoid the use of necrotic drugs to reduce inflammation in 175 
delicate tissues such as the eye in the case of AK, or the brain in GAE. Maslinic acid is 176 
well tolerated in mice (45) and rat (46) and we know that humans tolerate caffeine well, 177 
but it remains to be seen if either drug can be safely and comfortably introduced to the 178 
eye surface (or the brain) at the required concentration to be an effective treatment. The 179 
fact that maslinic acid inhibits encystment, is toxic to cysts and trophozoites and the 180 
killing mechanism acts through PCD makes this an especially promising candidate for 181 
AK treatment. 182 
 183 
MATERIAL AND METHODS 184 
Acanthamoeba strains.  185 
Three clinical isolates (CLC-16, genotype T3; CLC-41.r, genotype T4 and CLC-51, 186 
genotype T1) obtained in a previous study in our laboratory (47) and the type strain 187 
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Acanthamoeba Neff (ATCC 30010, genotype T4) were used in this study. These strains 188 
were grown axenically in PYG medium [0.75 % (w/v) proteose peptone, 0.75 % (w/v) 189 
yeast extract and 1.5 % (w/v) glucose] containing 40 μg/ml gentamicin (Biochrom AG, 190 
Cultek, Granollers, Barcelona, Spain) at room temperature. 191 
Chemicals. Two drugs were selected for the different experiments: caffeine (Sigma-192 
Aldrich Chemistry Ltd.; Madrid, Spain) and maslinic acid (was kindly provided by 193 
Instituto de Biotecnología, Department of Parasitology, University of Granada, Spain). 194 
Their results were compared with chlorhexidine (chlorhexidine digluconate; Alfa Aesar) 195 
and amphotericin B (Sigma-Aldrich Chemistry Ltd.; Madrid, Spain), used as reference 196 
drugs.  197 
Activity assays. The anti-trophozoite activities of the assayed drugs were determined by 198 
the AlamarBlue® assay as previously described (47, 48, 49).  199 
Cysticidal activity. The effect of the assayed drugs against cyst was evaluated incubating 200 
105 cells/ml of Acanthamoeba Neff with the previously calculated IC90 in Neff´s 201 
Encystment Medium (induces encystation of amoebic strains) (NEM; 0.1 M KCl, 8 mM 202 
MgSO4·7H2O, 0.4 mM CaCl2·2H2O, 1 mM NaHCO3, 20 mM ammediol [2-amino-2-203 
methyl-1,3-propanediol] Sigma Aldrich Chemistry Ltd., Madrid, Spain, pH 8.8, at 25 ºC). 204 
After 24, 48 and 72 h, samples were collected in flow cytometry tubes where they were 205 
stained with the vital stain Congo Red (Fisher Scientific) at 10 g/ml for 30 minutes. This 206 
stain has a high affinity for cellulose, making it is useful to stain mature cysts.  207 
Samples were analysed by flow cytometry using a BD FACS CantoTM II (Becton & 208 
Dickinson) and the software BD FACS Diva. The different populations of cells were 209 
separated accordingly to size and complexity, as follow: P1 total population; P2 cysts; P3 210 
trophozoites; P4 cysts stained with Congo Red; P5 pre-cysts stained with Congo Red.  211 
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Cell proliferation. In order to study the effect of the tested active compounds on the 212 
Acanthamoeba Neff cell proliferation, a Cell Proliferation ELISA, BrdU (colourimetric) 213 
kit was used (Roche) following the manufacture’s recommendations and as previously 214 
described (49).  215 
Mammalian Cytotoxicity test. The cytotoxicity produced by active compounds was 216 
evaluated against cell lines from mammals: murine macrophages (ATCC TIB-67) and 217 
HeLa cells (ATCC CCL-2). A Cytotoxicity Detection Kit (LDH) (Roche Applied 218 
Science) was used following the manufacture’s recommendations. Results were classified 219 
based on a previously establish parameters. The active principles that have percentages 220 
of cytotoxicity between 0-10%, were defined as being non- cytotoxic. Values between 221 
10-25% as having low cytotoxicity, 25-40%, as having moderate cytotoxicity while 222 
values >40%, have high cytotoxicity (14, 49).  223 
Cellular DNA Fragmentation. A cellular DNA fragmentation kit (Roche) was used. 224 
This kit is an Enzyme-Linked ImmunoSorbent Assay (ELISA) for the detection of BrdU-225 
labeled DNA fragments in culture supernatants and cellular lysates. The procedure for 226 
characterization of cell death consists in two parts: 1. Analysis of supernatant which will 227 
contain DNA fragments at early stages of necrosis and late stages of apoptosis. 2. The 228 
remaining cells are lysed in order to release apoptotic DNA fragments located in the 229 
cytoplasm. The experiment was carried out following manufacturer recommendations 230 
and as previously described (34).  231 
Double Stain assay for apoptosis determination. A double stain apoptosis detection kit 232 
(Hoechst 33342/PI) (Genscript, Piscataway, NJ, USA) and an inverted confocal 233 
microscope (Leica DMI 4000B) was used. The experiment was carried out following 234 
manufactures recommendations and as previously described (34). 105 cells/well were 235 
incubated in a 24-well plate for 24h with the previously calculated IC50 (Table 1). The 236 
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double staining pattern allows the identification of three groups in a cellular population: 237 
live cells will show only a low level of blue Hoechst 33342 fluorescence; apoptotic cells 238 
will show a higher level of blue fluorescence, and dead cells will show low-blue and high-239 
red propidium iodide (PI) fluorescence, as this dye only penetrates dead cells. 240 
Plasma membrane permeability. SYTOX® Green nucleic acid stain (Invitrogen, Life 241 
Technologies SA, Madrid, Spain) is a high-affinity nucleic acid stain (absorption and 242 
emission maxima at 504 and 523 nm, respectively) that rendering cells with compromised 243 
plasma membranes brightly green fluorescent. 244 
Experiment was carried out following manufacturers´ recommendations and as a 245 
previously described (34). A positive control with 2.5% of triton X-100 (Sigma) was 246 
added in order to obtain fully permeabilized cells.  247 
Caspase-like activity detection. A Caspase-3 Colorimetric Assay Kit (Genscript, 248 
Piscataway, NJ, USA) was used following manufacturers´ recommendations and as a 249 
previously described study (34). The assay is based on the chromophore p-nitroalanine 250 
which is coupled to a peptide containing the caspase-3 substrate DEVD. On completion 251 
the optical density (at 405 nm) of the experiment is compared to controls to determine 252 
caspase-3 activity. 253 
Statistical analysis. The obtained results were compared by one-way ANOVA and 254 
multiple Post-hoc analysis and Tukey’s test using the Sigma Plot 12.0 software (Systat 255 
Software). 256 
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FIGURE LEGENDS 442 
Table 1. The AlamarBlue® cell viability assay was used to determine IC50 and IC90 (M) 443 
values (after 96 hours) for caffeine and maslinic acid tested against the four strains of 444 
Acanthamoeba. 445 
 446 
Figure 1. Acanthamoeba Neff separated into sub-populations after 72h: P1, total cell 447 
population, analysed by the flowcytometer; P2, cysts; P3, trophozoites, analysed 448 
according to size and complexity of cells. P4, cysts; P5, precysts, analysed by 449 
fluorescence emitted by the Congo Red staining. A. Control. B. Cells after treatment with 450 
caffeine IC90. C. Cells after treatment with maslinic acid IC90.  451 
Figure 2. Observed cell proliferation after incubation of Acanthamoeba Neff strain with 452 
caffeine and maslinic acid using the previously obtained IC50 and IC90 compared to the 453 
control. Results were analysed at 24, 48 and 72h. A. Effects on cell proliferation when 454 
cells were treated with caffeine. B. Effects on cell proliferation when cells were treated 455 
with maslinic acid. Statistically between both concentration and the control were 456 
observed (*** p < 0.001; ** p < 0.01; * p < 0.05).  457 
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Figure 3. Cytotoxicity levels of the tested caffeine and maslinic acid against 458 
Acanthamoeba (IC50 and IC90) were evaluated against two cell lines: HeLa and murine 459 
macrophages. Values lower than 10% correspond to a null cytotoxicity, so the results 460 
showed that caffeine IC50 (C50), caffeine IC90 (C90) and maslinic acid IC50 (M50) were 461 
not cytotoxic. Values between 10-25% correspond to a low cytotoxicity, which was the 462 
case of maslinic acid IC90 (M90). Statistical differences between the assayed drugs and 463 
the cytotoxicity produced by the reference ones, chlorhexidine IC90 (Chx90) and 464 
amphotericine B (Anf90) was observed in both cell lines (*** p < 0.001).  465 
Figure 4. Amount of DNA detected over time in the culture supernatant and cell lysate 466 
(Absorbance Vs Time). A. Caffeine. B. Maslinic acid. Statistically differences (*** p < 467 
0.001; * p < 0.05) are showed comparing results obtained between supernatants (filled 468 
symbols) and cell lysate (empty symbols) values. 469 
Figure 5. Hoechst staining is different in control cells, where uniformly faint blue nuclei 470 
are observed, and in treated cells (at 24h), where the nuclei are bright blue. A-C Phase 471 
contrast where A is the Control, B caffeine (IC50) and C maslinic acid (IC50). D-F Hoechst 472 
channel where D is the Control, E caffeine and F maslinic acid. G-I Propidium Iodine 473 
channel were G is the Control, H caffeine and I maslinic acid. Scale bars are 25m. 474 
Figure 6. Permeabilization of the cellular membrane. Fluorescence from the SYTOX® 475 
Green nucleic acid stain can be observed when cells were treated with the different 476 
treatments after 2 hours. A. Control. B. Caffeine. C. Maslinic acid. D. Differences 477 
between the total permeabilization control (addition of triton) and the drug treated cells 478 
were apparent when fluorescence of the cells was measured. Statistically differences (*** 479 
p < 0.001; ** p < 0.01) are showed comparing results obtained between negative control 480 
and the different treatments. Scale bars are 25m. 481 
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Figure 7. Histogram where cells and treatments are compared. Results are represented in 482 
percentages and statistically differences (*** p < 0.001) are showed comparing apoptotic 483 
cells after treatments with the control.  484 
Figure 8. Caspase-like activity (2-72h) (Absorbance vs Time). Statistically differences 485 
(*** p < 0.001; ** p < 0.01; *** p < 0.05) are showed comparing control with the different 486 
concentrations. A. Caffeine. B. Maslinic acid.  487 
